Latest Breaking News On - Des meuniers - Page 1 : comparemela.com

Genomic Vision Announces the Issuance of the 3rd Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 Million

Genomic Vision Announces the Issuance of the 3rd Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalAaron bensimonCompany parisStrategic communicationsRegulatory newsGenomic visionExecutive boardDes marchDes meuniersManagement board

Genomic Vision: Financial Information for the First Quarter of 2023

Revenue from activity +12% in Q1 2023 to €435 thousands Sales of products and services +13% in Q1 2023 to €321 thousands The Company is well funded for 2023 Regulatory News: Genomic

France generalUnited statesAaron bensimonConsilium strategic communicationsInternational investor relationsStrategic communicationsResearch tax creditResearch taxGenomic visionUniversal registration documentationDes meuniersGene editingSupport teamsFriday septemberTuesday novemberInvestor relations

Genomic Vision: 2022 Annual Results

Genomic Vision: 2022 Annual Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomMohammad afsharElisabeth ourliacEmilie chataignierEric ederyTammou abikhzerAaron bensimonLionel seltzDominique remy renouFlorence alloucheStrategic communicationsGovernance committee of the companyVp sciencesConsilium strategic communicationsCompany supervisory board

Genomic Vision announces the issuance of the 2nd tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million

Regulatory News: Genomic Vision (the "Company" FR0011799907 GV) (Paris:GV), a biotechnology company that develops products and services for the highly accurate characterization of DNA sequences

France generalDennis riedlAaron bensimonStrategic communicationsGenomic vision the companyRegulatory newsGenomic visionExecutive boardDes meuniers

Genomic Vision announces the issuance of the 2nd tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million

Genomic Vision announces the issuance of the 2nd tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Genomic visionExecutive boardDes meuniers